Showing 1991-2000 of 2038 results for "".
- Nicox Establishes High-Profile Glaucoma Clinical Advisory Boardhttps://modernod.com/news/nicox-establishes-high-profile-glaucoma-clinical-advisory-board/2479601/Nicox SA announced the formation of Nicox Glaucoma Clinical Advisory Board, composed of key clinical investigators and opinion leaders in the field, to support and guide the development of its innovative NO-donating compounds as potential IOP-lowering drugs.
- Joe Garibaldi Appointed Vice President of US Sales at Optovuehttps://modernod.com/news/joe-garibaldi-appointed-vice-president-of-us-sales-at-optovue/2476172/Joe Garibaldi has been appointed to vice president of US Sales at Optovue, where he will continue to lead the US sales force as well as identify new strategic partnering opportunities to grow the company’s US product portfolio. Garibaldi joined Optovue in 2009 as a territory manager and he
- Cultivating 4-D Tissues: The Self-Curving Corneahttps://modernod.com/news/cultivating-4-d-tissues-the-self-curving-cornea/2476176/Scientists at Newcastle University have developed a biological system which lets cells form a desired shape by moulding their surrounding material—in the first instance creating a self-curving cornea. In the research, a flat circle of gel containing corneal stromal cells (stem
- Takeda CEO Optimistic About Growth Prospects as Drugmaker Finalizes Shire Takeoverhttps://modernod.com/news/takeda-ceo-optimistic-about-growth-prospects-as-drugmaker-finalizes-shire-takeover/2476205/Takeda announced that it has completed its $62-billion acquisition of Shire. Christophe Weber, chief executive of Takeda, stated “this marks a significant moment in [our] history and is an exciting step forward as we accelerate our transformation journey to deliver highly-innovative medicin
- Focus Vision Supplements Launches Reformulated Version of Omega-3 Focus Relief Plushttps://modernod.com/news/focus-vision-supplements-launches-reformulated-version-of-omega-3-focus-relief-plus/2476228/Covalent Medical, a network of over 385 ophthalmologists who distribute vision supplements sold in practitioners’ offices in the United States under the brand name Focus Vision Supplements, is launching a reformulated version of their leading omega-3 formulation Focus Relief Plus. Focus Re
- Imprimis Pharmaceuticals Changes Name to Harrow Healthhttps://modernod.com/news/imprimis-pharmaceuticals-changes-name-to-harrow-health/2476233/Imprimis Pharmaceuticals announced it has formally changed its name to Harrow Health and began trading as “HROW” on the NASDAQ Capital Markets on January 2, 2019. “Our new name reflects our business model of c
- Alcon Introduces New Medical Affairs Website in North America, Expanding Support for Patient Care and Clinical Communityhttps://modernod.com/news/alcon-introduces-new-medical-affairs-website-in-north-america-expanding-support-for-patient-care-and-clinical-community/2476149/Alcon recently launched a new website, AlconScience.com, for US- and Canada-based eye care professionals and academic institutions. The new medical affairs website consolidates information about Alcon’s scientific, academic, and related activities into one portal. Visitors may download clinically
- Clearside Presents Additional Analyses of PEACHTREE Clinical Trial Data in Support of Xipere in Treating Uveitic Macular Edemahttps://modernod.com/news/clearside-presents-additional-analyses-of-peachtree-clinical-trial-data-in-support-of-xipere-in-treating-uveitic-macular-edema/2476155/Clearside Biomedical recently announced that additional data from PEACHTREE, the company’s pivotal phase 3 trial of Xipere (formerly suprachoroidal CLS-TA) in patients with uveitic macular edema, were presented by Rahul N. Khurana, MD, Vitreoretinal Surgeon at Northern California
- Spark Therapeutics Gene Therapy Pioneers Win $1 Million Sanford Lorraine Cross Awardhttps://modernod.com/news/spark-therapeutics-gene-therapy-pioneers-win-1-million-sanford-lorraine-cross-award/2476159/Two women with a vision to make the blind see were the winners of the inaugural $1 million Sanford Lorraine Cross Award. Jean Bennett, MD, PhD, and Katherine A. High, MD, whose work with the RPE65 mutation has reversed an inherited form of blindness, accepted the award on December 4 at Sanford He
- Study: Ocular Technology Provides Early Detection of Alzheimer’s Diseasehttps://modernod.com/news/study-ocular-technology-provides-early-detection-of-alzheimers-disease/2479626/A recent study from JAMA Ophthalmology finds that a specific type of noninvasive eye testing procedure may help assess risk for Alzheimer’s disease. One in 10 Americans over the age 65 has Alzheimer’s, while one-third over the age of 85 have the disease. Fortunately, res